indazoles has been researched along with transferrin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, M; Keppler, B; Kratz, F; Messori, L | 1 |
| Hartinger, CG; Keppler, BK; Rudnev, AV; Semenova, O; Timerbaev, AR | 1 |
| Groessl, M; Hann, S; Hartinger, CG; Keppler, BK; Koellensperger, G; Rudnev, AV; Stingeder, G; Sulyok, M; Timerbaev, AR | 1 |
| Arion, VB; Eichinger, A; Graf von Keyserlingk, N; Jakupec, MA; Kapitza, S; Keppler, BK; Marian, B; Pongratz, M; Reisner, E | 1 |
| Abramski, JK; Hartinger, CG; Jarosz, M; Keppler, BK; Polec-Pawlak, K; Semenova, O; Timerbaev, AR | 1 |
| Hartinger, CG; Jakupec, MA; Keppler, BK; Kynast, B; Zorbas, H; Zorbas-Seifried, S | 1 |
| Abramski, JK; Foteeva, LS; Hartinger, CG; Jarosz, M; Keppler, BK; Połeć-Pawlak, K; Rudnev, AV; Timerbaev, AR | 1 |
| Abramski, JK; Ferenc, J; Foteeva, LS; Jarosz, M; Keppler, BK; Połeć-Pawlak, K; Timerbaev, AR | 1 |
| Groessl, M; Hartinger, CG; Jarosz, M; Keppler, BK; Polec-Pawlak, K | 1 |
| Alex, D; Drescher, A; Grubert, M; Henke, MM; Hilger, RA; Jaehde, U; Richly, H; Scheulen, ME; Thyssen, D | 1 |
| Jarosz, M; Matczuk, M; Pawlak, K; Timerbaev, AR | 1 |
| Chetcuti, ARM; Lay, PA; Levina, A | 1 |
1 review(s) available for indazoles and transferrin
| Article | Year |
|---|---|
From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA; Humans; Indazoles; Models, Molecular; Organometallic Compounds; Ruthenium Compounds; Transferrin | 2006 |
1 trial(s) available for indazoles and transferrin
| Article | Year |
|---|---|
Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma.
Topics: Antineoplastic Agents; Blood Chemical Analysis; Blood Proteins; Electrophoresis, Capillary; Humans; In Vitro Techniques; Indazoles; Mass Spectrometry; Neoplasms; Organometallic Compounds; Protein Binding; Ruthenium Compounds; Serum Albumin; Transferrin | 2008 |
10 other study(ies) available for indazoles and transferrin
| Article | Year |
|---|---|
The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.
Topics: Antineoplastic Agents; Apoproteins; Chromatography, High Pressure Liquid; Humans; Imidazoles; Indazoles; Magnetic Resonance Spectroscopy; Molecular Structure; Organometallic Compounds; Protein Binding; Ruthenium; Spectrophotometry; Transferrin | 1994 |
Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis.
Topics: Antineoplastic Agents; Blood Protein Electrophoresis; Electrophoresis, Capillary; Humans; Hydrolysis; Indazoles; Organometallic Compounds; Protein Binding; Ruthenium Compounds; Serum Albumin; Transferrin | 2005 |
Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins--significance for the patient.
Topics: Albumins; Antineoplastic Agents; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Humans; Indazoles; Neoplasms; Organometallic Compounds; Protein Binding; Ruthenium; Ruthenium Compounds; Spectrometry, Mass, Electrospray Ionization; Transferrin | 2005 |
KP1019 (FFC14A) from bench to bedside: preclinical and early clinical development--an overview.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Drug Evaluation, Preclinical; Humans; Indazoles; Organometallic Compounds; Oxidation-Reduction; Ruthenium Compounds; Transferrin | 2005 |
Platinum group metallodrug-protein binding studies by capillary electrophoresis - inductively coupled plasma-mass spectrometry: a further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins.
Topics: Antineoplastic Agents; Binding, Competitive; Blood Proteins; Electrophoresis, Capillary; Humans; In Vitro Techniques; Indazoles; Kinetics; Mass Spectrometry; Organometallic Compounds; Platinum; Protein Binding; Ruthenium Compounds; Serum Albumin; Transferrin | 2006 |
Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using CE.
Topics: Ascorbic Acid; Blood Proteins; Buffers; Drug Stability; Electrolytes; Electrophoresis, Capillary; Glutathione; Indazoles; Mass Spectrometry; Organometallic Compounds; Oxidation-Reduction; Ruthenium Compounds; Serum Albumin; Spectrophotometry, Ultraviolet; Transferrin | 2007 |
Application of capillary electrophoresis-inductively coupled plasma mass spectrometry to comparative studying of the reactivity of antitumor ruthenium(III) complexes differing in the nature of counter-ion toward human serum proteins.
Topics: Algorithms; Antineoplastic Agents; Blood Proteins; Capillary Electrochromatography; Humans; Indazoles; Indicators and Reagents; Kinetics; Mass Spectrometry; Organometallic Compounds; Ruthenium Compounds; Serum Albumin; Solutions; Transferrin | 2008 |
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors.
Topics: Antineoplastic Agents; Biomarkers; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; DNA Adducts; Dose-Response Relationship, Drug; Half-Life; Humans; Indazoles; Infusions, Intravenous; Leukocytes; Metabolic Clearance Rate; Neoplasms; Organometallic Compounds; Ruthenium Compounds; Serum Albumin; Transferrin | 2009 |
Molecular mass spectrometry in metallodrug development: a case of mapping transferrin-mediated transformations for a ruthenium(III) anticancer drug.
Topics: Antineoplastic Agents; Biological Transport; Biotransformation; Coordination Complexes; Drug Discovery; Indazoles; Models, Molecular; Molecular Weight; Organometallic Compounds; Protein Conformation; Ruthenium; Spectrometry, Mass, Electrospray Ionization; Transferrin | 2014 |
Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs.
Topics: Antineoplastic Agents; Ferric Compounds; Humans; Indazoles; Organometallic Compounds; Receptors, Transferrin; Ruthenium; Ruthenium Compounds; Serum Albumin; Transferrin | 2022 |